Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 3/20 | 0.34 |
| ▸ | CNR1 | P21554 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | IAPP | P10997 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5039126 | 1.00 | CNR2 (0.34) | CNR2CNR1ALDH1A1KDM4EGAA | |
| SCHEMBL11706822 | 0.89 | CYP3A4 (0.36) | CNR2CNR1 | |
| SCHEMBL5131346 | 0.89 | CNR2 (0.41) | CNR2CNR1ALDH1A1KDM4EGAA | |
| SCHEMBL931488 | 0.86 | LIPG (0.44) | CNR1KDM4E | |
| SCHEMBL4503938 | 0.85 | GABRA1 (0.40) | ALDH1A1DAOESR2 | |
| SCHEMBL18905417 | 0.81 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL4950642 | 0.81 | ALDH1A1 (0.34) | ALDH1A1DAO | |
| SCHEMBL78218 | 0.80 | ALDH1A1 (0.41) | ALDH1A1 | |
| SCHEMBL9310371 | 0.79 | ALDH1A1 (0.33) | ALDH1A1KDM4EGAAHPGDDAO | |
| SCHEMBL16951878 | 0.79 | ALDH1A1 (0.33) | ALDH1A1DAOESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545780-B2 | Flexible metal clad laminates and methods of preparation thereof | NOTARK CORPORATION (US) | 2026-02-10 | — | — | US | disclosed |
| US-20260035495-A1 | FUNCTIONAL COPOLYMERS AND METHODS OF PREPARATION THEREOF | Kraton Corporation (US) | 2026-02-05 | — | — | US | disclosed |
| US-20240067810-A1 | FLEXIBLE METAL CLAD LAMINATES AND METHODS OF PREPARATION THEREOF | Kraton Corporation (US) | 2024-02-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035495-A1 | FUNCTIONAL COPOLYMERS AND METHODS OF PREPARATION THEREOF | VCL, FGB, CDH1 | CNR2 2805/4885CNR1 2971/4885ALDH1A1 303/4885 |
| US-12545780-B2 | Flexible metal clad laminates and methods of preparation thereof | DSG1, CDH1, CAD | CNR2 1901/4885CNR1 2020/4885ALDH1A1 480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.